- Home
- CMMB vs INBS Comparison
CMMB vs INBS Comparison
Compare CMMB & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- INBS
- Stock Information
- Founded
- CMMB 2004
- INBS 2016
- Country
- CMMB Israel
- INBS United States
- Employees
- CMMB N/A
- INBS N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- CMMB Health Care
- INBS Health Care
- Exchange
- CMMB Nasdaq
- INBS Nasdaq
- Market Cap
- CMMB 13.7M
- INBS 11.7M
- IPO Year
- CMMB N/A
- INBS N/A
- Fundamental
- Price
- CMMB $3.28
- INBS $1.03
- Analyst Decision
- CMMB Strong Buy
- INBS
- Analyst Count
- CMMB 2
- INBS 0
- Target Price
- CMMB $26.50
- INBS N/A
- AVG Volume (30 Days)
- CMMB 260.4K
- INBS 199.0K
- Earning Date
- CMMB 11-13-2025
- INBS 11-06-2025
- Dividend Yield
- CMMB N/A
- INBS N/A
- EPS Growth
- CMMB N/A
- INBS N/A
- EPS
- CMMB N/A
- INBS N/A
- Revenue
- CMMB N/A
- INBS $3,052,532.00
- Revenue This Year
- CMMB N/A
- INBS $778.48
- Revenue Next Year
- CMMB N/A
- INBS N/A
- P/E Ratio
- CMMB N/A
- INBS N/A
- Revenue Growth
- CMMB N/A
- INBS N/A
- 52 Week Low
- CMMB $2.39
- INBS $1.01
- 52 Week High
- CMMB $9.84
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- CMMB 59.76
- INBS 34.56
- Support Level
- CMMB $3.03
- INBS $1.02
- Resistance Level
- CMMB $3.50
- INBS $1.17
- Average True Range (ATR)
- CMMB 0.21
- INBS 0.07
- MACD
- CMMB 0.02
- INBS 0.00
- Stochastic Oscillator
- CMMB 64.21
- INBS 6.25
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).